Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (7237)	10/24/2002 11:04:44 AM
From: keokalani'nui	Read Replies (2) \| Respond to of 52153

Serious question: Is there a treatise on biotech patent law? Comment out of ignorance: I can not understand why the discoverer of an enzyme who elucidates its purpose and invents one or more compounds to silence or activate the enzyme has not earned a patent on the entire discovery, including the underlying natural process. Perhaps with the first application of the doctrine of equivalents, this was effectively the result. It would seem appropriate patent policy to me to give the discoverer a fixed term monopoly (otherwise, why bother to discover?), except of course if the target is NF-KB and (like me) you have a financial interest in proteasome inhibition. That is a totally different story. <g>